Your Journey To Health
GlobeStar Therapeutics Corporation (OTCQB: GSTC) is a pioneer in the field of Multiple Sclerosis and other diseases. Our transformative therapies for the management of chronic neurodegenerative diseases are life-changing. Our patented therapies introduce a formulation of previously approved drugs which have been shown in clinical trials to improve the quality of life for these patients.
Are you a GlobeStar investor or interested in becoming one? Learn more about us and the benefits that come from joining our team.
GlobeStar Therapeutics Corporation (OTCBB: GSTC) is an American biotechnology company originally organized in 2011, headquartered in Houston, Texas with offices in the State of Washington, focused on developing innovative therapies for people with serious and life-threating rare disorders.
The Company patented and sold for $10 million of preferred shares a treatment for peripheral artery disease (PAD) called LiprostinTM followed by acquiring an exclusive license for a patented method of treating neurodegenerative diseases such as Multiple Sclerosis by administering a synergistically effective amount of the composition to an individual suffering from neurodegeneration and treating neurodegeneration.
We are in discussions with several contract research organizations to assist with our submission of new drug application for global marketing.
Years of Experience
In The News
As a publicly traded company, GlobeStar provides news on its operations through press release distributors like business wire, but it provides the same news here in an expanded format with links to all of the initial released locations and expanded images. this conforms to regulation FD disclosure requirements.
Oftentimes, when someone first begins to deal with symptoms from a neurodegenerative disease they will start to notice a plethora of uncomfortable, unsettling, and overall painful feelings that must be treated with medical help. Listed below will be a list of signs...
Multiple Sclerosis affects people all over the world. In fact, many are unsure of what the obvious signs of Multiple Sclerosis are, and how they can tell if they are suffering from it or not. It is important to note that while you may have a symptom here or there,...
AngioSoma, Inc., Soon To Be GlobeStar Therapeutics Corporation, Welcomes Dr. Michael Lewis, MD, MPH, MBA, FACPM, FACN To The Medical Advisory Board
Dr. Lewis's medical experience and research background will play a significant role in AngioSoma. RICHLAND, WA / ACCESSWIRE / June 22, 2021 / AngioSoma, Inc. (OTC PINK:SOAN) has added Dr. Michael Lewis, MD, to the Medical Advisory Board. Dr. Lewis's experience in...